Malaria is a serious, potentially fatal infection caused by parasites that spread to humans through mosquito bites. It kills roughly 597,000 people each year and causes an estimated 263 million infections worldwide, with the vast majority of deaths occurring in sub-Saharan Africa among young children. Despite being both preventable and treatable, malaria remains one of the leading infectious disease threats globally.
What Causes Malaria
Malaria is caused by single-celled parasites in the Plasmodium family. Four species primarily infect humans: P. falciparum, P. vivax, P. ovale, and P. malariae. A fifth species, P. knowlesi, normally infects monkeys but occasionally jumps to humans in parts of Southeast Asia.
P. falciparum is the most widespread and the most dangerous. It’s the species most likely to cause severe illness, including brain involvement (cerebral malaria), kidney failure, severe anemia, and respiratory distress. P. vivax is the second most common and has a unique trait: it can hide dormant in the liver for months or even years, causing relapses long after the initial mosquito bite. P. ovale shares this relapsing ability but is much less common. P. malariae causes a milder form of the disease but can persist in the blood at very low levels for decades if untreated.
How It Spreads
Malaria spreads when a female Anopheles mosquito bites someone who’s already infected, picks up the parasite, and then bites another person. During that second bite, the mosquito injects microscopic forms of the parasite, called sporozoites, into the skin along with its saliva. These parasites travel through the bloodstream to the liver, where they multiply silently for days to weeks before bursting into the blood and infecting red blood cells.
Once inside red blood cells, the parasites multiply further, eventually destroying those cells and releasing a new wave of parasites to infect more red blood cells. This cycle of invasion, multiplication, and cell destruction is what drives the classic symptoms of malaria. In rare cases, malaria can also spread through blood transfusions, organ transplants, or from a pregnant mother to her baby.
Symptoms and Timing
Symptoms typically appear 7 to 30 days after a mosquito bite. P. falciparum tends to cause symptoms on the earlier end of that window, while P. malariae sits at the longer end. The initial signs often resemble the flu and can be easy to dismiss:
- Fever and chills
- Sweating
- Headache
- Nausea and vomiting
- Body aches
- General fatigue and feeling unwell
A hallmark pattern in some cases is cyclical fevers, where chills, high fever, and drenching sweats repeat every two or three days as synchronized waves of red blood cells burst. Not everyone develops this classic pattern, though, especially early in the illness. Because the symptoms overlap with so many common infections, malaria is easy to miss in people who don’t mention recent travel to a region where the disease is common.
Severe malaria develops when the infection overwhelms the body’s defenses, most often with P. falciparum. It can progress rapidly, sometimes within hours. Warning signs include confusion or unusual drowsiness, difficulty breathing, very dark urine, jaundice (yellowing of the skin and eyes), and extreme weakness. Children under five and pregnant women face the highest risk of severe disease, as do travelers from non-endemic countries who have no prior immune exposure.
How Malaria Is Diagnosed
The gold standard for diagnosing malaria is examining a blood sample under a microscope. A trained lab technician can identify the parasite inside red blood cells on a stained blood smear and determine both the species and how heavily the blood is infected. This level of detail matters because it directly affects treatment decisions.
In many parts of the world where malaria is common, however, microscopes and trained technicians aren’t always available. Rapid diagnostic tests (RDTs) were developed to fill that gap. These finger-prick tests detect proteins released by the parasite and can return results in about 15 minutes. The tradeoff is accuracy: RDTs perform well when the parasite load is high, but they can miss infections when parasite levels in the blood are low. In one study of children in Nigeria, 71% of microscopy-confirmed infections were missed by the rapid test, largely because of low parasite density. For this reason, a negative rapid test doesn’t always rule malaria out, especially if symptoms are suggestive.
Treatment
Malaria is treatable, and early treatment dramatically reduces the risk of complications. The specific approach depends on which parasite species is involved and where the infection was acquired, because drug resistance varies by region.
For the most dangerous form caused by P. falciparum, the preferred treatment in most of the world is a combination therapy built around artemisinin, a plant-derived compound that clears parasites from the blood rapidly. These combination treatments pair artemisinin with a longer-acting partner drug to mop up remaining parasites over several days. Treatment courses typically last three days, though infections picked up in Southeast Asia may require a seven-day course because of higher rates of drug resistance in that region.
For P. vivax and P. ovale infections, treatment has an extra step. Because these species can lie dormant in liver cells, patients need an additional course of medication specifically targeting those dormant forms to prevent relapses weeks or months later. Without this step, the infection can return even after the blood-stage parasites have been cleared.
Severe malaria is a medical emergency that requires hospitalization and intravenous treatment. With prompt care, most people recover. Without it, the disease can be fatal within days or even hours.
Prevention
Insecticide-treated bed nets are the single most effective tool for preventing malaria transmission. Large trials involving over 200,000 participants found that sleeping under treated nets reduces child mortality from all causes by 17% and cuts the rate of uncomplicated P. falciparum malaria episodes nearly in half. Severe malaria episodes dropped by 44%. Even compared to plain, untreated nets, the insecticide-treated versions provide significantly better protection, reducing malaria episodes by about 42%.
Indoor residual spraying, where the walls and ceilings of homes are coated with insecticide, is another pillar of malaria control. Mosquitoes that land on treated surfaces after feeding are killed before they can bite again. Travelers to malaria-endemic areas can also take preventive medications before, during, and after their trip. The specific drug depends on the destination and the traveler’s medical history, but these regimens are highly effective when taken as directed.
Personal measures help too. Anopheles mosquitoes feed primarily between dusk and dawn, so wearing long sleeves and pants in the evening, using insect repellent, and sleeping in screened or air-conditioned rooms all reduce exposure.
Malaria Vaccines
After decades of effort, two malaria vaccines are now available for children in endemic regions. The first, RTS,S, showed 55% efficacy against clinical malaria episodes in its first year in pediatric trials across Africa. A newer vaccine, R21/Matrix-M, performed even better, with 72% efficacy against clinical episodes in the first year. Both target P. falciparum and are designed for young children, the group at highest risk of dying from the disease.
These vaccines don’t eliminate the risk entirely, so they work best as an added layer on top of bed nets, spraying, and prompt treatment. Still, in a disease that kills more than half a million people a year, even partial protection at the population level translates to tens of thousands of lives saved. Multiple African countries have begun rolling out vaccination programs, with broader deployment ongoing.